Diiodohydroxyquinoline
GENITO URINARY SYSTEM AND SEX HORMONES
Also known as: diiodohydroxyquin, diiodoquin, diiodoquinol, iodoquinol
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Diiodohydroxyquinoline is a drug catalogued in DrugCentral. DrugCentral lists 11 molecular targets, including MAPK1, MAPK14 and ADORA3. Recorded indications include Amebic infection.
- Molecular targets: MAPK1, MAPK14, ADORA3 and ACE (11 listed in DrugCentral).
- Indications: Amebic infection.
- ATC code: G01AC01 (Quinoline derivatives).
- Molecular formula: C9H5I2NO; molecular weight 396.95 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Amebic infection
Off-label uses (6)
- Atopic dermatitis
- Contact dermatitis
- Eruption of skin
- Lichen simplex chronicus
- Pruritus ani
- Pruritus of genital organs
Contraindications (7)
- Adrenal cortical hypofunction
- Atrophoderma
- Disease of liver
- Optic neuritis
- Peripheral nerve disease
- Peripheral vascular disease
- Telangiectasia disorder
Mechanism & targets
Molecular targets (11)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Mitogen-activated protein kinase 1 | MAPK1 | unknown | IC50 6.53 |
| Mitogen-activated protein kinase 14 | MAPK14 | unknown | IC50 6.44 |
| Adenosine receptor A3 | ADORA3 | unknown | Ki 6.28 |
| Angiotensin-converting enzyme | ACE | unknown | IC50 6.04 |
| Tyrosine-protein kinase Fyn | FYN | unknown | IC50 5.80 |
| Epidermal growth factor receptor | EGFR | unknown | IC50 5.72 |
| Tyrosine-protein kinase Lck | LCK | unknown | IC50 5.61 |
| Beta-lactamase NDM-1 | blaNDM-1 | unknown | IC50 5.60 |
| Mitogen-activated protein kinase 3 | MAPK3 | unknown | IC50 5.28 |
| Catechol O-methyltransferase | Comt | unknown | IC50 5.25 |
| Receptor tyrosine-protein kinase erbB-2 | ERBB2 | unknown | IC50 5.07 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| — | FDA | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
G01AC01 | GENITO URINARY SYSTEM AND SEX HORMONES › GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS › ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS › Quinoline derivatives |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Diiodohydroxyquinoline is on its molecule page.
| Molecular formula | C9H5I2NO |
|---|---|
| Molecular weight | 396.95 g/mol |
| CAS number | 83-73-8 |
| InChIKey | UXZFQZANDVDGMM-UHFFFAOYSA-N |
| PubChem CID | 3728 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Diiodohydroxyquinoline used for?
DrugCentral lists the following indications for Diiodohydroxyquinoline: Amebic infection.
How does Diiodohydroxyquinoline work?
Its molecular targets in DrugCentral include MAPK1, MAPK14, ADORA3 and ACE.
What is the chemical formula of Diiodohydroxyquinoline?
Diiodohydroxyquinoline has the molecular formula C9H5I2NO and a molecular weight of 396.95 g/mol.
Browse: all drugs starting with D · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1457 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL86754 — compound record and bioactivity
- PubChem CID 3728 — chemical identifiers
- DrugBank DB09115 — drug record
- FDA UNII 63W7IE88K8 — substance identity
- DailyMed: FDA labels for Diiodohydroxyquinoline — current prescribing information (label search)
- UniProt P28482 (MAPK1) — target protein
- UniProt Q16539 (MAPK14) — target protein
- UniProt P0DMS8 (ADORA3) — target protein
- UniProt P06241 (FYN) — target protein
- UniProt P00533 (EGFR) — target protein
- UniProt P06239 (LCK) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.